Clinical Trials
2
Active:0
Completed:2
Trial Phases
2 Phases
Phase 1:1
Phase 2:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials
Phase 1
1 (50.0%)Phase 2
1 (50.0%)Safety and Immunogenicity of a Single Dose of Intranasal Seasonal Trivalent Live-Attenuated Influenza Vaccine
Phase 2
Completed
- Conditions
- Influenza
- First Posted Date
- 2012-06-21
- Last Posted Date
- 2015-06-01
- Lead Sponsor
- PATH Vaccine Solutions
- Target Recruit Count
- 309
- Registration Number
- NCT01625689
- Locations
- 🇧🇩
ICDDR,B Kamalapur, Dhaka, Bangladesh
Phase I Safety Trial of Streptococcus Pneumoniae Whole Cell Vaccine (SPWCV) + Alum in Healthy Adults
Phase 1
Completed
- Conditions
- Pneumococcal Vaccines
- First Posted Date
- 2012-02-23
- Last Posted Date
- 2014-06-05
- Lead Sponsor
- PATH Vaccine Solutions
- Target Recruit Count
- 42
- Registration Number
- NCT01537185
- Locations
- 🇺🇸
Comprehensive Clinical Development, Tacoma, Washington, United States
News
No news found